The European Hematology Exam: The Next Step toward the Harmonization of Hematology Training in Europe

José‐Tomás Navarro(Universitat Autònoma de Barcelona), António Almeida(Hospital da Luz), Cheng‐Hock Toh(University of Liverpool), Naomi van Hattem(European Hematology Association), Wietske W.G. Hollegien(European Hematology Association), Manon T. Saris(European Hematology Association), Gunnar Birgegård(Uppsala University Hospital), Mariëlle J. Wondergem(Amsterdam UMC Location Vrije Universiteit Amsterdam), Janet Strivens(University of Liverpool)
HemaSphere
September 27, 2019
10.1097/hs9.0000000000000291
Cited by 3

Related Papers

Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
|Journal of Clinical Oncology|2012|461
The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): International Prospective Validation and Reliability Trial in 402 patients
|Blood|2011|340
Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms
|Journal of Clinical Oncology|2011|244
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients
|Blood|2013|189
Human immunodeficiency virus‐associated plasmablastic lymphoma
|Cancer|2012|178